Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Accounts receivables, net allowance $ 183,242 $ 348,695
Preferred Stock, Shares authorized 10,000,000 10,000,000
Preferred Stock, Par Value $ 0.001 $ 0.001
Preferred Stock, Issued 0 0
Preferred Stock, Outstanding 0 0
Common Stock, Shares authorized 65,000,000 65,000,000
Common Stock, par value $ 0.001 $ 0.001
Common Stock, Issued 24,411,098 23,523,969
Common Stock, Outstanding 24,411,098 23,523,969